CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 88 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2021. The put-call ratio across all filers is 0.04 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $74,030,000 | -21.0% | 626,789 | -25.7% | 0.08% | -14.9% |
| Q3 2020 | $93,694,000 | +47.1% | 843,027 | +35.3% | 0.09% | +70.9% |
| Q2 2020 | $63,673,000 | +134.7% | 623,141 | +147.9% | 0.06% | +111.5% |
| Q1 2020 | $27,133,000 | +410.1% | 251,396 | +450.1% | 0.03% | +550.0% |
| Q4 2019 | $5,319,000 | +209.8% | 45,700 | +204.7% | 0.00% | +300.0% |
| Q3 2019 | $1,717,000 | +98.0% | 15,000 | +64.8% | 0.00% | 0.0% |
| Q2 2019 | $867,000 | -69.4% | 9,100 | -70.6% | 0.00% | -66.7% |
| Q1 2019 | $2,829,000 | +360.0% | 31,000 | +282.7% | 0.00% | +200.0% |
| Q4 2018 | $615,000 | -86.0% | 8,100 | -85.2% | 0.00% | -80.0% |
| Q3 2018 | $4,384,000 | -79.4% | 54,800 | -76.7% | 0.01% | -58.3% |
| Q2 2018 | $21,325,000 | +135.7% | 235,300 | +110.7% | 0.01% | +20.0% |
| Q1 2018 | $9,048,000 | +12.3% | 111,700 | +9.2% | 0.01% | +11.1% |
| Q4 2017 | $8,058,000 | -56.8% | 102,300 | -49.4% | 0.01% | -59.1% |
| Q3 2017 | $18,648,000 | – | 202,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VERNIER CAPITAL PARTNERS, LP | 137,557 | $11,142,000 | 6.62% |
| COMGEST GLOBAL INVESTORS S.A.S. | 637,752 | $51,658,000 | 1.13% |
| Black Creek Investment Management Inc. | 411,525 | $33,334,000 | 1.09% |
| Hillhouse Capital Management | 618,391 | $50,090,000 | 0.88% |
| RUDMAN ERROL M | 21,301 | $1,725,000 | 0.83% |
| JUPITER ASSET MANAGEMENT LTD | 263,705 | $21,360,000 | 0.65% |
| York Capital Management Global Advisors, LLC | 341,616 | $27,671,000 | 0.62% |
| VONTOBEL ASSET MANAGEMENT INC | 873,968 | $71,525,000 | 0.51% |
| Temasek Holdings (Private) Ltd | 990,000 | $80,190,000 | 0.44% |
| WASATCH ADVISORS LP | 292,216 | $23,669,000 | 0.31% |